IRIS
LAZZARINO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.835
AS - Asia 5.614
EU - Europa 4.347
SA - Sud America 583
AF - Africa 119
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 17.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.701
CN - Cina 3.049
SG - Singapore 1.140
IE - Irlanda 819
UA - Ucraina 807
HK - Hong Kong 625
DE - Germania 531
FI - Finlandia 521
BR - Brasile 423
RU - Federazione Russa 347
VN - Vietnam 340
SE - Svezia 322
IT - Italia 311
FR - Francia 289
GB - Regno Unito 241
IN - India 106
CA - Canada 72
AR - Argentina 55
BD - Bangladesh 53
ZA - Sudafrica 46
IQ - Iraq 44
MX - Messico 42
NL - Olanda 36
JP - Giappone 35
TR - Turchia 30
PK - Pakistan 26
VE - Venezuela 25
BE - Belgio 24
ID - Indonesia 24
PL - Polonia 22
ES - Italia 21
EC - Ecuador 19
CO - Colombia 17
PH - Filippine 17
SA - Arabia Saudita 17
PY - Paraguay 16
JO - Giordania 15
TN - Tunisia 13
KE - Kenya 11
CL - Cile 10
LT - Lituania 10
MA - Marocco 10
MY - Malesia 10
UZ - Uzbekistan 10
AZ - Azerbaigian 8
IR - Iran 8
PE - Perù 8
AU - Australia 7
IL - Israele 7
MU - Mauritius 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
BO - Bolivia 6
DZ - Algeria 6
PA - Panama 6
CZ - Repubblica Ceca 5
EG - Egitto 5
EU - Europa 5
KZ - Kazakistan 5
OM - Oman 5
AO - Angola 4
GR - Grecia 4
JM - Giamaica 4
LV - Lettonia 4
NG - Nigeria 4
RO - Romania 4
SN - Senegal 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CR - Costa Rica 3
ET - Etiopia 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
MN - Mongolia 3
NP - Nepal 3
PT - Portogallo 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MZ - Mozambico 2
PS - Palestinian Territory 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HN - Honduras 1
Totale 17.500
Salva come PNG Salva come JPEG
Città #
Jacksonville 957
Chandler 922
Dublin 819
Nanjing 765
Hong Kong 615
Singapore 560
San Jose 541
Ashburn 515
Dallas 390
Boardman 346
Beijing 342
Nanchang 294
New York 246
Hebei 213
Princeton 206
Shenyang 204
Lawrence 202
Medford 196
Changsha 187
Lauterbourg 170
Wilmington 169
Jiaxing 155
Los Angeles 147
Ann Arbor 141
Tianjin 120
Hangzhou 119
Ho Chi Minh City 115
Helsinki 88
Buffalo 86
Hanoi 86
Milan 78
Redondo Beach 58
Moscow 56
Woodbridge 52
Shanghai 50
Verona 48
Falkenstein 45
Munich 37
São Paulo 37
Norwalk 35
Tokyo 32
Toronto 31
Johannesburg 29
Santa Clara 29
Turku 29
Orem 28
Seattle 27
Des Moines 25
Brussels 24
Frankfurt am Main 24
Jinan 23
Brooklyn 22
Montreal 21
Rome 20
Baghdad 19
Warsaw 19
Zhengzhou 18
Auburn Hills 17
Da Nang 17
Houston 17
Kunming 17
Fairfield 16
Ningbo 16
Stockholm 16
San Francisco 15
Chicago 14
London 14
Amman 13
Guangzhou 13
Haiphong 13
The Dalles 13
Amsterdam 12
Ankara 12
Chennai 12
Pavia 12
Pune 12
Rio de Janeiro 12
Atlanta 11
Belo Horizonte 11
Lanzhou 11
Mexico City 11
Nuremberg 11
Dhaka 10
Manchester 10
Nairobi 10
Taizhou 10
Tashkent 10
Guayaquil 9
Brasília 8
Denver 8
Phoenix 8
Quito 8
Secaucus 8
Biên Hòa 7
Bogotá 7
Buenos Aires 7
Chongqing 7
Curitiba 7
Dalian 7
New Delhi 7
Totale 11.318
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 185
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 178
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 155
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implicatios for serologic staging. 152
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 143
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 142
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 141
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) 141
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 138
Blast phase of essential thrombocythemia: A single center study. 137
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 135
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. 132
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 130
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 127
EFFICACY OF PIPOBROMAN IN THE TREATMENT OF POLYCYTHEMIA VERA: LONG TERM RESULTS IN 163 PATIENTS 125
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 125
Splenic nodal and extranodal marginal zone lymphoma: features of bone marrow involvement. 123
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial 122
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. 121
Adult ki-1-positive large cell anaplastic lymphoma presenting with skin lesions. 121
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 118
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 116
Multiple granulocytic sarcoma during complete hematologic remission of acute nonlymphoid leukemia. 116
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 115
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 115
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 115
ALK+ lymphoma: clinico-pathological findings and outcome. 113
A young woman with microcytic anemia and hypertransaminasemia 113
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 109
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. 109
ABL1 amplification in T-cell acute lymphoblastic leukemia. 109
JAK2 (V617F) mutation in healthy individuals 108
Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection 107
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 107
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 106
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 105
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia 105
Pharmacokinetic behavior of Rituximab: a study of different schedules of administration for heterogeneous clinical settings. 104
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 104
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 103
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 103
Etoposide : il citostatico della linea monocitica 102
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 102
EFFICACY OF A IDARUBICIN, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE ARABINOSIDE AS SALVAGE THERAPY IN RELAPSING OR RESISTANT UNFAVORABLE LYMPHOMA 101
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy 100
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 100
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 100
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. 100
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. 99
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 99
Central nervous system relapse in acute promyelocytic leucemia 98
Management of nodal diffuse large B-cell lymphomas : practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation 98
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases 97
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 97
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. 97
Clinical characteristics and outcome of immunoglobulin M-related disorders 96
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 96
Valutazione prognostica dele sindromi mielodisplastiche 95
Evolving approaches with alpha interferon in chronic myelogenous leukemia 95
Treatment of relapsed and refractory acute myloid leukemia in adults 94
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 94
Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years. 93
Late onset of bortezomib-associated cutaneous reaction following herpes zoster 93
Lymph node reticulum cell neoplasm with progression into cytokeration-positive interstitial reticulum cell (CIRC) sarcoma: a case study 92
Carateristiche cliniche peculiari delle leucemie acute monocitiche e loro rilievo prognostico 92
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features. 92
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 92
Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases 91
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 91
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 91
Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls 90
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 90
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 89
Urinary proteins in multiple myeloma. correlation with clinical parameters and diagnostic implications 88
A striking response to bortezomib in a patient with pleural localization of multiple myeloma 88
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 88
Primary gastric CD30 (Ki-1)positive large cell Non Hodgkin Lymphomas. A clinicopathologic analysis six cases. 88
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 87
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 87
TREATMENT OF EARLY STAGE HODGKIN’S DISEASE WITH FOUR CYCLES OF ABVD FOLLOWED BY ADJUVANT RADIOTHERAPY: ANALYSIS OF EFFICACY AND LONG TERM TOXICITY 87
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. 87
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. 86
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma. 86
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 86
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. 85
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. 84
Interferon-alfa plus low-dose cytosine arabinoside in advanced phase chronic myeologenus leukaemia patients. 84
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 84
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 84
Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment 83
Long-term outcome of ph-negative acute lymphoblastic leukaemia in adults: a single centre experience. 83
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 83
Complicanze emorragiche e trombotiche nel paziente chirurgico 83
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. 82
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 82
Treatment of Ph1 positive chronic myelogenous leukemia with interferon alpha-2b (IFN 2b) 82
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 81
Il ruolo del trapianto autologo nei linfomi non-Hodgkin indolenti 81
Mitoxantrone: clinical safety and tolerance in hematologic malignancies 81
Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset 80
Totale 10.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021431 0 0 0 0 0 0 0 0 0 197 198 36
2021/2022905 17 10 30 13 25 43 10 49 46 26 136 500
2022/20232.621 295 169 28 222 328 292 1 168 995 20 78 25
2023/20241.018 98 166 28 88 75 398 11 71 10 18 31 24
2024/20252.367 43 236 70 78 63 55 78 236 515 51 223 719
2025/20264.898 392 426 581 554 540 291 1.084 195 462 373 0 0
Totale 17.641